The Introduction of Generic Risperidone in Medicare Part D

Lignende værker

• CB7-02: Medicare Part D Cost-sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems
  af: Fung, Vicki, et al.
  Udgivet: (2012)
• Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs: Linking Health Insurance Benefits and Clinical Needs
  af: Fung, Vicki, et al.
  Udgivet: (2013)
• Distributing $800 Billion: An Early Assessment of the Medicare Part D Risk Adjustment Approach
  af: Hsu, John, et al.
  Udgivet: (2009)
• Assessment of Behavioral Health Services Use Among Low-Income Medicare Beneficiaries After Reductions in Coinsurance Fees
  af: Fung, Vicki, et al.
  Udgivet: (2020)
• The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma
  af: Newhouse Joseph P, et al.
  Udgivet: (2008-07-01)